| End Notes |
| Putting it in Perspective
[1] Gina Kolata, “A Widely Used Arthritis Drug Is Withdrawn,” The New York Times, October 1, 2004, http://0-web.lexis-nexis.com.libra.nazlib.org. [2] Sara Beardsley, “Avoiding Another Vioxx,” Scientific America, 292 (Feb 2005) 16, http://0-web17.epnet.com.libra.nazlib.org. [3] Gina Kolata, “A Widely Used…”. [4] NIHCM Foundation, “Prescription Drugs and Mass Media Advertising: 1999-2000,” NIHCM DTC Report, 7, www.nihcm.org/DTCbrief2001.pdf. DTCA History [1] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer Prescription Drug Advertising Regulation,” Food and Drug Law Journal, 57 (November 3, 2002), 425, http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14372 [2] Ibid, 426. [3] Ibid, 426. [1] http://www.ethicad.org/pharma/dtc/ads.html [2] United States Department of Health and Human Services, Food And Drug Administration, Center for Devices and Radiological Health, Office of Compliance, “Draft Guidance for Industry and FDA: Consumer-Directed Broadcast Advertising of Restricted Devices,” (1997), 3, http://www.fda.gov/cdrh/comp/guidance/1513.pdf. [3] Ibid. [4] NIHCM Foundation, 3. [5]
Tamar Nordenberg,
“Direct to You: TV Drug Ads That Make Sense,” [6] Ibid. [7] United States Department of Health and Human Services, Food And Drug Administration, Center for Devices and Radiological Health, Office of Compliance, “Draft Guidance for Industry and FDA: Consumer-Directed Broadcast Advertising of Restricted Devices,” (1997), 2, http://www.fda.gov/cdrh/comp/guidance/1513.pdf. [8] Ibid, 3. [9] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer...", 431 [10] Ibid, 429. [11] Ibid. [12] Tamar Nordenberg, "Direct to you...", 5. [13] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer...",430. [14] Amy Tsao, "Viagra: A Drug Ad Too Far?," Business Week Online, (November 17, 2004), 2, http://0-web17.epnet.com.libra.nazlib.org. [15]
Larry
D. Sasich, Parm.D., M.P.H. “Comments on Food and Drug
Administration’s Draft Guidance for Industry on Direct to Consumer
Advertising,” Public Citizen (October 1997), 4, http://www.citizen.org/publications/release.cfm?ID=6626. [16] United States General Accounting Office, "FDA Oversight of Direct-to-Consumer Advertising has Limitations," (2002), 6 http://www.gao.gov/atext/d03177.txt DTCA Today [1] NIHCM Foundation…12 [2] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer...", 424. [3] Ibid, 423. [4] Barbara Mintzes, and others, “How Does DTCA affect Prescribing? A Survey in Primary Care Environments with and without Legal DTCA,” Canadian Medical Association Journal, 169 (Septmeber 2003) 1-2, http://0-web17.epnet.com.libra.nazlib.org. [5] Ibid, 2. [6] Martin S. Lipsky, Christine A. Taylor, “The opinions and experiences of family physicians regarding direct-to-consumer advertising,” Journal of Family Practice, v45 n6, (1997), 495. [7] Ibid, 500. [8] Tamar V. Terzian, "Direct-to-Consumer Prescription Drug Advertising," American Journal of Law and Medicine, 25 (1999), 5,http://0-web17.epnet.com.libra.nazlib.org. [9] Janice Rosenberg, “Patient Orders: When Patients Ask for Specific Drugs,” American Medical News (March 2001), 1, http://www.ama-assn.org/amednews/2001/03/19/hlsa0319.htm. [10] Ibid. [11]Victoria Stagg Elliot, “FDA Survey Puts Positive Spin on Direct-to-Consumer Ads,” Amednews.com (Feb 2003), 2, http://www.ama-assn.org/amednews/2003/02/03/hlsb0203.htm. [12] NIHCM Foundation, 13. [13] Kathryn Aikin, “The Impact of Direct-to-Consumer Prescription Drug Advertising on the Physician Patient Relationship," FDA, 2003, http://www.fda.gov/cder/ddmac/aikin. [14] Victoria Stagg Elliot, “FDA Survey Puts Positive Spin on Direct-to-Consumer Ads,”2. [15] Ibid. [16] Larry D. Sasich, Parm.D., M.P.H. “Comments on Food and Drug Administration’s Draft Guidance for Industry on Direct to Consumer Advertising,” Public Citizen (October 1997), 2, http://www.citizen.org/publications/release.cfm?ID=6626. [17] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer...",440. Potential Solutions [1] See Mintzes, Lipsky, Sasich. [2] Tamar Nordenberg, “Direct to You: TV Drug Ads That Make Sense...”,2. [3] Michael S. Shaw, "The DTC Dilemma," Ethicad, 5, http://www/ethicad/org/dilemma.pdf. [4] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer...",424. [5] United States Department of Health and Human Services, Food And Drug Administration, Center for Devices and Radiological Health, Office of Compliance, “Draft Guidance for Industry and FDA: Consumer-Directed Broadcast Advertising of Restricted Devices,” (1997), 3, http://www.fda.gov/cdrh/comp/guidance/1513.pdf. [6] United States General Accounting Office, “Prescription Drugs: Little is Known About the Effects of Direct-to Consumer Advertising,” (1991), 14, http://161.203.16.4/d19t9/144561.pdf. Cost/Benefit [1] "Draft Guidance...",2. [2] NIHCM Foundation, "Prescription Drugs and Mass...",2. [3] U.S. Congress, Senate Committee on Finance, FDA Merck and Vioxx: Putting Patient Safety First?, November 18, 2004, http://finance.senate.gov. [4] Francis B. Palumbo, C. Daniel Mullins, “The Development of Direct-to-Consumer...", 435. [5] Martin S. Lipsky, Christine A. Taylor, “The opinions and experiences...", 3.
|